肿瘤在免疫逃逸和化疗耐药下的消除与控制策略
Strategies for tumor elimination and control under immune evasion and chemotherapy resistance
AI总结:
研究通过数学模型分析免疫逃逸策略下肿瘤细胞与效应细胞的相互作用,揭示治疗强度对肿瘤持续、消除及表型主导的阈值条件,为设计靶向和联合疗法提供理论依据。
摘要:
肿瘤在免疫反应和治疗干预下的进化和生态动态对长期治疗成功构成重大挑战。尽管治疗可能最初实现短期疾病控制,但耐药癌细胞亚群常出现,导致复发时疾病更具侵袭性和治疗耐受性。本文开发并分析了描述效应细胞、化疗耐药肿瘤细胞和免疫耐受肿瘤细胞之间相互作用的数学模型,其中包含耐药和敏感肿瘤亚群之间的竞争与合作。我们确定了在不同治疗强度下肿瘤持续、消除和表型主导的阈值条件。这些发现为设计靶向和联合疗法提供了理论框架,并提供了缓解治疗耐药性的策略见解。
英文摘要:
The evolutionary and ecological dynamics of tumors under immune responses and therapeutic interventions pose major challenges to long-term treatment success. Although treatment may initially achieve short-term disease control, resistant cancer cell subpopulations often arise, leading to relapse with more aggressive and treatment-resistant forms of the disease. Here, we develop and analyze mathematical models describing the interactions among effector cells, chemo-resistant tumor cells, and immuno-resistant tumor cells under distinct immune-evasion strategies. The models incorporate competition and cooperation between resistant and sensitive tumor subpopulations. We identify threshold conditions governing tumor persistence, elimination, and phenotype dominance under varying therapeutic intensities. These findings provide a theoretical framework for designing targeted and combination therapies and offer insights into strategies for mitigating the treatment resistance.
机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。